Verastem, Inc.
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
Verastem, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker VSTMno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20174.35
11.10.20174.62
04.10.20174.82
27.09.20174.67
20.09.20175.15
13.09.20175.25
06.09.20174.92
30.08.20173.85
23.08.20173.55
16.08.20173.24
09.08.20173.56
02.08.20173.67
26.07.20173.58
19.07.20173.43
12.07.20174.09
05.07.20172.43
27.06.20172.28
20.06.20172.18
13.06.20172.09
06.06.20172.17
30.05.20172.34
23.05.20172.40
16.05.20172.35
09.05.20172.06
02.05.20172.08
25.04.20171.79
18.04.20171.94
11.04.20171.74
04.04.20171.98
28.03.20171.90
21.03.20171.54
14.03.20171.37
07.03.20171.19
28.02.20171.14
21.02.20171.25
14.02.20171.24
07.02.20171.24
31.01.20171.27
24.01.20171.30
17.01.20171.17
10.01.20171.21
03.01.20171.15
27.12.20161.15
19.12.20161.19
12.12.20161.17
05.12.20161.07
28.11.20161.17
21.11.20161.21
14.11.20161.27
07.11.20161.13
31.10.20161.25
24.10.20161.34
17.10.20161.38
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 4.35n/a
Market Capitalisation
in million USD
 161n/a
Enterprise Value
in million USD
 68n/a
Common Shares Outstanding
as per Aug 2, 2016
 36,992,418n/a
Preferred Shares Outstanding
as per Aug 2, 2016
 n/a
Average Basic Shares Outstanding
TTM
 36,962,250n/a
Average Diluted Shares Outstanding
TTM
 n/a
Index Membership
n/a
Business Summary
Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income -45n/a
EBITDA -44n/a
Net Profit -44n/a
Balance Sheet
Cash and Cash Equivalents 93n/a
Receivables 0n/a
Total Current Assets 94n/a
PP&E 2n/a
Total Assets 95n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 6n/a
Long-Term Debt 0n/a
Total Liabilities 6n/a
Total Equity 89n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -4n/a
Operating Cash Flow -39n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 44n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 4n/a
Free Cash Flow -48n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity -49.6%n/a
Return on Assets -46.3%n/a
Per Share Figures
Basic EPS -1.20n/a
Diluted EPS n/a
Sales per Share 0.00n/a
Book Value per Share 2.41n/a
FCF per Share -1.29n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -3.64n/a
Price to Sales Ratio n/a
Price to Book Value 1.81n/a
Price to Free Cash Flow -3.37n/a
Valuation Metrics
EV/EBITDA -1.55n/a
EV/Sales n/a
Book to Market Value 0.55n/a
Other Ratios
Current Ratio 1,578.6%n/a
Liabilities to Equity Ratio 7.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Revenue
0
0
0
0
0
Sales & Services Revenue
0
0
0
0
0
Financing Revenue
0
0
0
0
0
Other Revenue
0
0
0
0
0
Cost of revenue
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Other Operating Income
0
0
0
0
0
Operating Expenses
-14
-32
-41
-54
-58
Selling, General & Administrative
-4
-11
-15
-18
-18
Selling & Marketing
0
0
0
0
0
General & Administrative
0
0
0
0
0
Research & Development
-10
-22
-26
-35
-41
Depreciation & Amortization
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
Operating Income (Loss)
-14
-32
-41
-54
-58
Non-Operating Income (Loss)
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
Interest Expense
0
0
0
0
0
Interest Income
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
Pretax Income (Loss), Adjusted
-14
-32
-41
-53
-58
Abnormal Gains (Losses)
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
Sale of Business
0
0
0
0
0
Legal Settlement
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
Pretax Income (Loss)
-14
-32
-41
-53
-58
Income Tax (Expense) Benefit, net
0
0
0
0
0
Current Income Tax
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
Income (Loss) from Continuing Operations
-14
-32
-41
-53
-58
Net Extraordinary Gains (Losses)
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
Income (Loss) Including Minority Interest
-14
-32
-41
-53
-58
Minority Interest
0
0
0
0
0
Net Income
-14
-32
-41
-53
-58
Preferred Dividends
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Net Income Available to Common Shareholders
-14
-32
-41
-53
-58
Remarks
restated on Mar 6, 2014 n/a
calculated values,
restated on Mar 10, 2015 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
48
57
101
93
110
Cash & Cash Equivalents
21
10
19
34
25
Short Term Investments
27
46
82
59
85
Accounts & Notes Receivable
0
0
0
0
0
Accounts Receivable, Net
0
0
0
0
0
Notes Receivable, Net
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
Inventories
0
0
0
0
0
Raw Materials
0
0
0
0
0
Work In Process
0
0
0
0
0
Finished Goods
0
0
0
0
0
Other Inventory
0
0
0
0
0
Other Short Term Assets
0
1
1
3
1
Prepaid Expenses
0
1
1
3
1
Derivative & Hedging Assets
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
Total Current Assets
48
57
102
95
111
Property, Plant & Equipment, Net
1
1
1
3
2
Property, Plant & Equipment
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
Long Term Investments & Receivables
9
35
22
0
0
Long Term Investments
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
Other Long Term Assets
1
0
0
1
0
Intangible Assets
0
0
0
0
0
Goodwill
0
0
0
0
0
Other Intangible Assets
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
Miscellaneous Long Term Assets
1
0
0
1
0
Total Noncurrent Assets
11
36
23
3
2
Total Assets
59
93
125
99
113
Liabilities and owners' equity
Payables & Accruals
3 3146000
2 2399000
7 7087000
9 8735000
10 10040000
Accounts Payable
2 2273000
2 1848000
3 2760000
3 3216000
4 3942000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
1 873000
1 551000
4 4327000
6 5519000
6 6098000
Short Term Debt
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 0
0 0
1 717000
0 469000
0 69000
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
1 717000
0 469000
0 69000
Total Current Liabilities
3 3146000
2 2399000
8 7804000
9 9204000
10 10109000
Long Term Debt
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
69 68657000
0 58000
0 11000
1 679000
1 516000
Accrued Liabilities
0 74000
0 38000
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
69 68583000
0 20000
0 11000
1 679000
1 516000
Total Noncurrent Liabilities
69 68657000
0 58000
0 11000
1 679000
1 516000
Total Liabilities
72 71803000
2 2457000
8 7815000
10 9883000
11 10625000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
2 1703000
137 136895000
205 205071000
230 229773000
301 301309000
Common Stock
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-14 -14467000
-46 -46451000
-88 -87653000
-141 -141018000
-199 -198883000
Other Equity
0 -2000
0 22000
0 28000
0 11000
0 43000
Equity Before Minority Interest
-13 -12766000
90 90466000
117 117446000
89 88766000
102 102469000
Minority Interest
0 0
0 0
0 0
0 0
0 0
Total Equity
-13 -12766000
90 90466000
117 117446000
89 88766000
102 102469000
Total Liabilities & Equity
59 59037000
93 92923000
125 125261000
99 98649000
113 113094000
Remarks restated on Mar 26, 2013 n/a restated on Mar 6, 2014 n/a restated on Mar 10, 2015 n/a restated on Mar 3, 2016 n/a restated on Aug 8, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-14
-32
-41
-53
-58
Net Income
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
1
Non-Cash Items
2
10
10
14
10
Stock-Based Compensation
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
Change in Working Capital
2
-1
5
2
1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
Cash from Operating Activities
-9
-23
-26
-37
-46
Change in Fixed Assets & Intangibles
-1
0
0
-2
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
Net Change in Long Term Investment
-36
-46
-23
46
-27
Decrease in Long Term Investment
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
Cash from Investing Activities
-37
-46
-23
43
-27
Dividends Paid
0
0
0
0
0
Cash From (Repayment of) Debt
64
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
Cash From (Repurchase of) Equity
-1
58
60
10
64
Increase in Capital Stock
-1
58
60
10
64
Decrease in Capital Stock
0
0
0
0
0
Other Financing Activities
0
0
-1
-1
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
Cash from Financing Activities
63
58
58
9
64
Net Cash Before Disc. Operations and FX
17
-11
9
15
-9
Change in Cash from Disc. Operations and Other
0
0
0
0
0
Net Cash Before FX
17
-11
9
15
-9
Effect of Foreign Exchange Rates
0
0
0
0
0
Net Changes in Cash
17
-11
9
15
-9
Remarks
restated on Mar 6, 2014 n/a
calculated values,
restated on Mar 10, 2015 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo